RAVEN Biotechnologies ravenbio.com


Public list: Pharma Startups (4733) Cancer Therapeutics (1136)

Raven biotechnologies is a privately held biotechnology company focused on the simultaneous discovery of novel cell surface drug targets and the antibody therapeutics to regulate them. Raven's integrated approach is based on proprietary, human tissue-specific progenitor and tumor cell lines developed at Raven, plus proprietary methods optimized for producing monoclonal antibodies (MAbs) targeting cell surface proteins. This platform rapidly identifies target antigens and therapeutic candidates i...Show all

Raven biotechnologies is a privately held biotechnology company focused on the simultaneous discovery of novel cell surface drug targets and the antibody therapeutics to regulate them. Raven's integrated approach is based on proprietary, human tissue...Show all

Company (Acquired)

Phone: 650-624-2600

Fax:

One Corporate Drive

South San Francisco, 94080
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
RAVEN Biotechnologies $109.7M Jul 22, 2008
Viventia $0M Sep 21, 2016
ImmunoVaccine Technologies $0M Oct 1, 2009
See all 41 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related RAVEN Biotechnologies Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 21 investors

Competitors

Company Status Description Investors
See all 41 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Luca2 and antibodies that bind thereto Jan 31, 2006 Dec 07, 2010 Patent
Human fetal bladder-derived epithelial cells Feb 12, 2003 Dec 07, 2010 Patent
Antibodies that bind to cancer-associated antigen cd46 and methods of use thereof Sep 19, 2006 Jun 29, 2010 Patent
Kid31 and antibodies that bind thereto Jan 12, 2006 Mar 30, 2010 Patent
Antibodies to oncostatin m receptor Feb 03, 2006 Aug 11, 2009 Patent
See all 8 patents